Indole compounds with N-ethyl morpholine moieties as CB2 receptor agonists for anti-inflammatory management of pain: synthesis and biological evaluation-Reference-Cited by-同舟云学术

Indole compounds with N-ethyl morpholine moieties as CB2 receptor agonists for anti-inflammatory management of pain: synthesis and biological evaluation

Published:2019 Issue:11 Volume:10 Page:1935-1947
ISSN:2040-2503
Container-title:MedChemComm
language:en
Short-container-title:Med. Chem. Commun.

Author:

Li Jiaojiao¹²³⁴^ORCID,Ji Jing¹²³⁴⁵,Xu Ruibo¹²³⁴,Li Zhengfu⁶²³⁷

Affiliation:

1. Pharmacy School

2. Jiangsu Ocean University

3. Lianyungang 222005

4. China

5. Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening

6. School of Computer Engineering

7. Chinali

Abstract

A series of indole compounds were designed and synthesized as CB2 agonist with high efficacy and selectivity.

Funder

Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions

Huaihai Institute of Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Pharmaceutical Science,Biochemistry,Drug Discovery,Molecular Medicine,Pharmacology,Organic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MD/C9MD00173E

Reference41 articles.

1. Medical uses of cannabinoids: the way forward

2. Structure of a cannabinoid receptor and functional expression of the cloned cDNA

3. Molecular characterization of a peripheral receptor for cannabinoids

4. The orphan receptor GPR55 is a novel cannabinoid receptor

5. An endocannabinoid mechanism for stress-induced analgesia

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The progress of small molecules against cannabinoid 2 receptor (CB2R);Bioorganic Chemistry;2024-03

2. Impact of Cannabinoid Receptors in the Design of Therapeutic Agents against Human Ailments;Current Topics in Medicinal Chemistry;2023-07

3. Rational drug design of CB2 receptor ligands: from 2012 to 2021;RSC Advances;2022

4. Occurrence of Morpholine in Central Nervous System Drug Discovery;ACS Chemical Neuroscience;2021-01-18

5. Chemical and pharmacological characterization of the TRPML calcium channel blockers ML-SI1 and ML-SI3;European Journal of Medicinal Chemistry;2021-01